Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:08 AM
Ignite Modification Date:
2025-12-25 @ 1:08 AM
NCT ID:
NCT00548093
Eligibility Criteria:
Inclusion Criteria:
* Advanced Non-Small Cell Lung Cancer (NSCLC)
* Prior treatment with and failure of at least one regimen of chemotherapy and erlotinib.
* Prior treatment with no more than two chemotherapy regimens, including adjuvant or combined modality treatment.
* Measurable disease .
* Eastern Cooperative Oncology Group (ECOG) Performance status 0-2
* Tissue available for KRAS/ EGFR testing
* Creatinine clearance \> 40 cc/min or serum creat \< 1.5 x ULN
Exclusion Criteria:
* Chemotherapy
* Radiotherapy
* Biological or investigational agents within 4 weeks of baseline disease assessment.
* Patients who lack of tolerance of erlotinib therapy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
99 Years
Study:
NCT00548093
Study Brief:
Protocol Section:
NCT00548093